Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001642
UniProt IDQ14693
Primary gene name(s)LPIN1
Synonym gene name(s)KIAA0188
Protein namePhosphatidate phosphatase LPIN1
Protein functionPlays important roles in controlling the metabolism of fatty acids at differents levels. Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis in the reticulum endoplasmic membrane. Acts also as a nuclear transcriptional coactivator for PPARGC1A/PPARA to modulate lipid metabolism gene expression, By similarity. Is involved in adipocyte differentiation. May also be involved in mitochondrial fission by converting phosphatidic acid to diacylglycerol, By similarity. {ECO:0000250}.
Subcellular locationNucleus membrane {ECO:0000250}. Cytoplasm, cytosol {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q14693
Gene Ontology
(Biological Process)
Complete annatation
animal organ regeneration [GO:0031100];
cellular response to insulin stimulus [GO:0032869];
fatty acid catabolic process [GO:0009062];
mitotic nuclear envelope disassembly [GO:0007077];
phosphatidylcholine biosynthetic process [GO:0006656];
phosphatidylethanolamine biosynthetic process [GO:0006646];
positive regulation of transcription from RNA polymerase II promoter [GO:0045944];
transcription, DNA-templated [GO:0006351];
triglyceride biosynthetic process [GO:0019432];
triglyceride mobilization [GO:0006642]
Gene Ontology
(Molecular Function)
Complete annatation
phosphatidate phosphatase activity [GO:0008195];
transcription coactivator activity [GO:0003713]
Gene Ontology
(Cellular Component)
Complete annatation
cytoplasm [GO:0005737];
cytosol [GO:0005829];
endoplasmic reticulum membrane [GO:0005789];
mitochondrial outer membrane [GO:0005741];
nuclear envelope [GO:0005635];
nuclear membrane [GO:0031965];
nucleoplasm [GO:0005654];
nucleus [GO:0005634]
Protein-protein interaction116787
Phylogenetic treeQ14693
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.7447752979464430.02365014049766820.0534896334905245
AZA vs. DISU0.1787387271182360.4801020999499960.931290574526604
AZA vs. IL70.009068320429699210.9623508003000480.999311006273513
AZA vs. SAHA0.2461471009733470.3131645645336350.684945247501454
DISU vs. CD30.9104136249230250.01300110121347210.0361117744042525
DISU vs. IL7-0.1786819185079260.4782695123046540.81294126650647
DISU vs. SAHA0.06932564008270880.8126100779764240.951385325391594
DMSO vs. AZA0.06166454456081050.7126051005254631
DMSO vs. CD30.7937502045769350.01358489840509050.0323127055240268
DMSO vs. DISU-0.1190558438641380.6258190700615820.944952148943607
DMSO vs. IL7-0.04529078608763260.8009727455640780.959270417912966
DMSO vs. SAHA0.1786075753267450.4486193357053740.7801917849545
HIV vs. Mock in Activation0.1190890686973260.8484743056823110.999983755607037
HIV vs. Mock in Latency0.02421284287487080.8831834935029460.999834320637052
IL7 vs. CD30.7608391998810980.0185417192400330.0492474597541881
SAHA vs. CD30.9665861778646630.006640294517118450.0181679808229802
SAHA vs. IL70.2337650432771630.337461394446810.587672488434752
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.568236 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.309 1.086 1.13 1.095 1.032
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00561 Glycerolipid metabolism - Homo sapiens (human)
hsa00564 Glycerophospholipid metabolism - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa04150 mTOR signaling pathway - Homo sapiens (human)